地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18771149750
传真:15172431432
邮箱:sales@amyjet.com

BiosPacific公司是R&D Systems 旗下专门为临床诊断试剂的研发与生产提供抗原、抗体(多抗、单抗、偶联的抗体、抗体对)的公司,在临床诊断试剂方面非常著名,是临床诊断试剂原料的全球供应商。BiosPacific公司是全球著名的临床诊断抗原抗体原料的供应商,其产品主要集中在癌症(肿瘤)、内分泌、传染病、人血清蛋白、甾类、血管病等标记物的优质单抗、多抗、抗原、偶联抗体,以及抗体对(matched pairs)。
As a manufacturer and supplier of antibodies and antigens of exceptional quality, for more than 29 years, BiosPacific is experienced in meeting the rigorous demands of the industrial client. Our success has been due, in large part, to our commitment to find the most effective solutions for your individual needs. Our expansive range of monoclonal antibodies, affinity purified polyclonal antibodies and purified proteins for immunoassay development allows us to support our customers collaboratively from feasibility to manufacturing. Browse by subject category such as cancer or cardiac markers below, or do a keyword search using the search field above.
BIOSPACIFIC产品的主要涵盖领域:
(1)Cancer
AFP, Alpha-2 Macroglobulin, Beta-2 Microglobulin, CA 125
(2)Endocrine Thyroid
ACTH, FSH, hCG, hGH, IGF-1, Insulin, LH, Proinsulin
(3)Steroids
Cortisol, Estradiol, Progesterone, Testosterone
(4)Cardio-vascular
CKBB, CKMB, CKMM, CRP, D-dimer, Myoglobin, TNI
(5)Human Serum Proteins
Albumin, Alpha-1 Antitrypsin, APO E,CRP, Hemoglobin
(6)Miscellaneous
Ferritin, Glucagon, IgE Myeloma Plasma, Stripped Serums, TPO
(7)Drugs
Amikacin, Amphetamine, Barbiturate, Benzodiazepine
(8)Infectious Diseases
Adenovirus, Chlamydia, CMV, Influenza A & B, HAV, HBcAg, Zika
(9)Medix Biochemica
AFP, CEA, CKMB, IgA, Myoglobin, RSV, SHBG, TSH
" data-original="http://prospec.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Biospacific"> Biospacific
VMRD公司位于美国华盛顿, 多年来一直致力于提供兽医学研究相关试剂和服务。公司业务领域包括: 诊断试剂盒, 荧光试剂盒, 抗体, 免疫试剂盒, 免疫检测服务。为客户提供高质量、高效率的产品和服务是VMRD一贯的宗旨。公司将不断开发兽医学产品,为世界健康服务。
VMRD was founded in 1981 by D. Scott Adams, DVM, PhD, and currently employs over 50 researchers, lab technicians and support personnel. From its site in Pullman, Washington VMRD develops and manufactures veterinary diagnostic test kits and related reagents for distribution in more than 77 countries. As a rapidly growing company, VMRD strives to preserve its family focused culture and core values of integrity and quality.
VMRD的主要产品包括:
Test Kits
Reagents
Antibodies
Coombs
Fluorescence
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://prospec.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="VMRD"> VMRD
DRG是一家专业医疗诊断试剂、设备的制造商和经销商,并在100多个国家有分支机构和合作伙伴。DRG®公司重点发展高科技精准医疗诊断产品,涉及领域有:肿瘤、妇科、内分泌科、糖尿病、自体免疫、传染病和毒理学等。DRG®还拥有高水准的专业医疗、临床、营销策划和服务方面的专家,通过与分布在世界各地的分公司及代理商的合作,DRG®公司为全世界的客户提供全方位质优创新的临床检验产品和服务。
DRG International, Inc. is a leading specialty medical diagnostics and equipment manufacturer, and distributor with operations in more than 110 countries. Founded in 1970, DRG International provides a complete range of products and services to the diagnostics and cardiology-related medical community. DRG International’s global headquarters is conveniently situated in Springfield, New Jersey, accessible from State Route 22 and minutes away from route I-78 and the Garden State Parkway. Only 20 miles from New York City and 80 miles from Philadelphia, PA, DRG International, Inc. is in the heart of the beautiful Tri-State Area.
DRG international公司的主要产品包括:
Chemiluminescence Immunoassays (CLAS)
Diabetes / Gastrointestinal and Pankreatic
Drug Monitoring
Endocrinology
Fertility and Pregnancy
Pituitary / Adrenal Function
Immunology / Hematology
Cardiovascular Diseases
Bone and Mineral Metabolism
Leukotrienes and Prostaglandins
Neuropeptides
Thyroid Function
Saliva Diagnostics
Tumor Diagnosis
Infectious Diseases
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://prospec.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="DRG International"> DRG International
Neuromab是一家由NIH资助成立的单克隆抗体库。
The UC Davis/NIH NeuroMab Facility is a national monoclonal antibody-generating resource funded by the National Institutes of Health (NIH). The mission of the UC Davis/NIH NeuroMab Facility is to provide a unique neuroscience-based approach to generating mouse monoclonal antibodies optimized for use in mammalian brain (NeuroMabs). NeuroMabs are generated from mice immunized with synthetic and recombinant immunogens corresponding to components of the neuronal proteome as predicted from genomic and other large-scale cloning efforts. Comprehensive biochemical and immunohistochemical analyses of human, primate and non-primate mammalian brain are incorporated into the UC Davis/NIH NeuroMab Facility screening procedure. This yields a subset of mouse mAbs that are optimized for use in brain (i.e., NeuroMabs): for immunohistochemical- based imaging studies of protein localization in adult, developing and pathological brain samples, for biochemical analyses of subunit composition and post-translational modifications of native brain proteins, and for proteomic analyses of native brain protein networks.
Neuromab的主要产品包括:
Array Tomography
Model Organisms
Disease Targets
产品列表:
| 抗体名称 |
| Anti-5-formylcytidine, NeuroMab clone N358/68 |
| Anti-5-hydroxymethylcytidine, NeuroMab clone N297/59 |
| Anti-6xHis, NeuroMab clone N144/14 |
| Anti-ADAM11, NeuroMab clone N441/35 |
| Anti-ADAM22-cytoplasmic, NeuroMab clone N46/30 |
| Anti-ADAM22-extracellular, NeuroMab clone N57/2 |
| Anti-AGPS neo-epitope, NeuroMab clone N444/63 |
| Anti-Aldh1L1 (Aldehyde dehydrogenase family 1 member L1), NeuroMab clone N103/39 |
| Anti-Aldh1L1 (Aldehyde dehydrogenase family 1 member L1), NeuroMab clone N103/31 |
| Anti-Alg13, NeuroMab clone N442/28 |
| Anti-Alpha-2C adrenergic receptor, NeuroMab clone N330A/80 |
| Anti-Alpha-2C adrenergic receptor, NeuroMab clone N330A/51 |
| Anti-AMIGO-1, NeuroMab clone L86/33 |
| Anti-AMIGO-1, NeuroMab clone L86/36 |
| Anti-AMIGO-1, NeuroMab clone L86A/37 |
| Anti-Ankyrin-B, NeuroMab clone N105/13 |
| Anti-Ankyrin-B, NeuroMab clone N105/17 |
| Anti-Ankyrin-G, NeuroMab clone N106/20 |
| Anti-Ankyrin-G, NeuroMab clone N106/36 |
| Anti-Ankyrin-G, NeuroMab clone N106/65 |
| Anti-Ankyrin-G, NeuroMab clone N106/43 |
| Anti-Ankyrin-R, NeuroMab clone N388A/10 |
| Anti-Ankyrin-R/G, NeuroMab clone N388A/27 |
| Anti-ANO3/TMEM16C, NeuroMab clone N454/91 |
| Anti-ANO5/TMEM16E, NeuroMab clone N421A/85 |
| Anti-ANO6/TMEM16F, NeuroMab clone N429/19 |
| Anti-ARHGAP4, NeuroMab clone N290B/25 |
| Anti-Arl13b, NeuroMab clone N295B/66 |
| Anti-Arx, NeuroMab clone N411/51 |
| Anti-ASIC1, NeuroMab clone N271/44 |
| Anti-ATAT1, NeuroMab clone N347/42 |
| Anti-Ataxin-1 11NQ, NeuroMab clone N76/8 |
| Anti-Ataxin-1 11NQ, NeuroMab clone N76/3 |
| Anti-Ataxin-1 wild-type, NeuroMab clone N65/37 |
| Anti-ATF4, NeuroMab clone N360A/24 |
| Anti-BAF53a, NeuroMab clone N336B/83 |
| Anti-BAF53b, NeuroMab clone N332B/15 |
| Anti-Bassoon, NeuroMab clone L124/59 |
| Anti-BBS3/Arl6, NeuroMab clone N302/10 |
| Anti-BBS5, NeuroMab clone N304B/115 |
| Anti-BDNF, NeuroMab clone N450/53 |
| Anti-Beta1-spectrin, NeuroMab clone N385/21 |
| Anti-Beta4-spectrin, NeuroMab clone N393/2 |
| Anti-Beta4-spectrin, NeuroMab clone N393/76 |
| Anti-BKBeta2 potassium channel subunit, NeuroMab clone N53/32 |
| Anti-BKBeta3a potassium channel subunit, NeuroMab clone N40B/18 |
| Anti-BKBeta4 potassium channel, NeuroMab clone L18A/3 |
| Anti-Botch1/Chac1, NeuroMab clone N116/14 |
| Anti-Bral1, NeuroMab clone N364/10 |
| Anti-Bral1, NeuroMab clone N364/42 |
| Anti-Brevican, NeuroMab clone N294A/6 |
| Anti-Brevican, NeuroMab clone N294A/10 |
| Anti-CALB1/calbindin, NeuroMab clone L109/39 |
| Anti-CALB1/calbindin, NeuroMab clone L109/57 |
| Anti-CALB2/calretinin, NeuroMab clone L122/6 |
| Anti-CALB2/calretinin, NeuroMab clone L122/68 |
| Anti-CASK scaffolding protein, NeuroMab clone K56A/50 |
| Anti-Caspr/paranodin/neurexin IV, NeuroMab clone K65/35 |
| Anti-Caspr2/paranodin, NeuroMab clone K67/25 |
| Anti-Cav1.2 calcium channel, NeuroMab clone L57/46 |
| Anti-Cav1.2, NeuroMab clone N263/31 |
| Anti-Cav1.3 calcium channel, NeuroMab clone L48A/9 |
| Anti-Cav1.3 calcium channel, NeuroMab clone N38/8 |
| Anti-Cav3.1 Ca2+ channel, NeuroMab clone N178A/9 |
| Anti-Cav3.2 calcium channel, NeuroMab clone N55/10 |
| Anti-Cav1 calcium channel, NeuroMab clone N7/18 |
| Anti-Cav尾2 calcium channel subunit, NeuroMab clone N8b/1 |
| Anti-Cav3 calcium channel, NeuroMab clone N473/36 |
| Anti-Cav尾4 calcium channel, NeuroMab clone N10/7 |
| Anti-Cdkl5, NeuroMab clone EA7 |
| Anti-CDY1/2, NeuroMab clone N143/38 |
| Anti-CDY1/2/L1/L2, NeuroMab clone N143/36 |
| Anti-Celf4/Brunol4, NeuroMab clone N446/80 |
| Anti-FOS, NeuroMab clone N486/32 |
| Anti-FOS, NeuroMab clone N486/76 |
| Anti-Clcn3, NeuroMab clone N258/5 |
| Anti-Clcn4, NeuroMab clone N222/6 |
| Anti-Clcn5, NeuroMab clone N406/47 |
| Anti-CLN3, NeuroMab clone N380/87 |
| Anti-CLN6, NeuroMab clone N400/24 |
| Anti-CNGA1/3 cyclic nucleotide-gated channel, NeuroMab clone L36/12 |
| Anti-Collybistin, NeuroMab clone L120/12 |
| Anti-Collybistin, NeuroMab clone L120/30 |
| Anti-Contactin/F3 scaffold protein, NeuroMab clone K73/20 |
| Anti-Copper-transporting ATPase 1, NeuroMab clone L60/4 |
| Anti-Copper-transporting ATPase 2 (Copper pump 2, Wilsons disease-associated protein, NeuroMab clone L62/29 |
| Anti-Co-Rest/RCOR1 Transcriptional Co-Repressor, NeuroMab clone K72/8 |
| Anti-DEPDC5, NeuroMab clone N463/52 |
| Anti-Dicer, NeuroMab clone N167/7 |
| Anti-DLX1 transcription factor, NeuroMab clone L43/40 |
| Anti-DNAH1, NeuroMab clone N251/14 |
| Anti-DNAH7, NeuroMab clone N250/21 |
| Anti-DNAIC1, NeuroMab clone UNC 65.56.18.11 |
| Anti-DNMT3L, NeuroMab clone N117/9 |
| Anti-Doc2b, NeuroMab clone N150/21 |
| Anti-Dopamine D2 receptor, NeuroMab clone N186/29 |
| Anti-Dopamine D3 receptor, NeuroMab clone N331/19 |
| Anti-EAAC1, NeuroMab clone N420/24 |
| Anti-FGF11 (Fibroblast growth factor 11), NeuroMab clone N92/14 |
| Anti-FGF12/FHF1, NeuroMab clone N94/17 |
| Anti-FGF13 (Fibroblast growth factor 13), NeuroMab clone N91/27 |
| Anti-FGF13B/FHF2B, NeuroMab clone N225A/10 |
| Anti-FGF14/FHF4, NeuroMab clone N56/21 |
| Anti-Fig4/Sac3, NeuroMab clone N202/7 |
| Anti-Flrt3, NeuroMab clone N353/13 |
| Anti-Foxi2, NeuroMab clone N349/96 |
| Anti-Foxi3, NeuroMab clone N359/28 |
| Anti-Frataxin, NeuroMab clone N191/7 |
| Anti-GABA-A-R-Alpha1, NeuroMab clone N95/35 |
| Anti-GABA-A-R-Alpha2, NeuroMab clone N399/19 |
| Anti-GABA-A-R-Alpha4, NeuroMab clone N398A/34 |
| Anti-GABA-A-R-Alpha5, NeuroMab clone N415/24 |
| Anti-GABA-A-R-Alpha6, NeuroMab clone N229A/32 |
| Anti-GABA-A-R-Beta1, NeuroMab clone N96/55 |
| Anti-GABA-A-R-Beta2/3, NeuroMab clone 62-3G1 |
| Anti-GABA-A-R-Beta3, NeuroMab clone N87/25 |
| Anti-Delta GABA-A receptor, NeuroMab clone N151/3 |
| Anti-GABA-A-R-Epsilon, NeuroMab clone N413/67 |
| Anti-GABA-A-R-Gamma2L, NeuroMab clone N452/69 |
| Anti-GABA-A-R-Gamma2L/S, NeuroMab clone N452/73 |
| Anti-GABA-A-R-Gamma2L/S, NeuroMab clone N452/30 |
| Anti-GABA-A-R-Pi, NeuroMab clone N431/64 |
| Anti- GABA-A-R-Theta, NeuroMab clone L123/109 |
| Anti-GABABR1 GABA-B receptor, NeuroMab clone N93A/49 |
| Anti-GABABR2 GABA-B receptor, NeuroMab clone N81/2 |
| Anti-GABABR2 GABA-B receptor, NeuroMab clone N81/37 |
| Anti-GAD65/67, NeuroMab clone L127/12 |
| Anti-GAD67, NeuroMab clone L127/8 |
| Anti-Gamma-protocadherin-A3, NeuroMab clone N144/17 |
| Anti-Gamma-protocadherin-B2, NeuroMab clone N148/30 |
| Anti-Gamma-protocadherin-C3, NeuroMab clone N174B/27 |
| Anti-Gamma-protocadherin-C4, NeuroMab clone N193A/13 |
| Anti-Gephyrin, NeuroMab clone L106/83 |
| Anti-Gephyrin, NeuroMab clone L106/93 |
| Anti-Gephyrin, NeuroMab clone L106/4 |
| Anti-GFAP, NeuroMab clone N206A/8 |
| Anti-GFAP-R416WT, NeuroMab clone N206B/9 |
| Anti-GFP (Green fluorescent protein), NeuroMab clone N86/8 |
| Anti-GFP (Green fluorescent protein), NeuroMab clone N86/38 |
| Anti-GFP (green fluorescent protein), NeuroMab clone N86/20 |
| Anti-GFP (green fluorescent protein), NeuroMab clone N86/44 |
| Anti-GIT1 scaffold protein, NeuroMab clone N39B/8 |
| Anti-GIT2 scaffold protein, NeuroMab clone N83/48 |
| Anti-GluA1/GluR1 glutamate receptor, NeuroMab clone N355/1 |
| Anti-GluA2/GluR2 glutamate receptor, NeuroMab clone L21/32 |
| Anti-KA2 kainate receptor, NeuroMab clone N279B/27 |
| Anti-GluN1/NR1 glutamate receptor, NeuroMab clone N308/48 |
| Anti-NR2A glutamate receptor, NeuroMab clone N327A/38 |
| Anti-GluN2A/NR2A glutamate receptor, NeuroMab clone N327/95 |
| Anti-GluN2B/NR2B glutamate receptor, NeuroMab clone N59/20 |
| Anti-GluN2B/NR2B glutamate receptor, NeuroMab clone N59/36 |
| Anti-GluN2C/NR2C, NeuroMab clone N422/18 |
| Anti- GluN3A/NR3A, NeuroMab clone N416/40 |
| Anti-Glycine receptor Alpha3, NeuroMab clone N424/45 |
| Anti-Glycine receptor Alpha3L, NeuroMab clone N424/48 |
| Anti-GRK6A/B, NeuroMab clone N142/28 |
| Anti-Gs protein alpha subunit, NeuroMab clone N192/12 |
| Anti-GST (Glutathione S-transferase), NeuroMab clone N100/13 |
| Anti-Haspin/GSG2, NeuroMab clone N128A/2 |
| Anti-HCN1 cyclic nucleotide-gated channel, NeuroMab clone N70/28 |
| Anti-HCN2 cyclic nucleotide-gated channel, NeuroMab clone N71/37 |
| Anti-HCN3 cyclic nucleotide-gated channel, NeuroMab clone N141/28 |
| Anti-HCN4 cyclic nucleotide-gated channel, NeuroMab clone N114/10 |
| Anti-Histone H2A.Z/V, NeuroMab clone N310/21 |
| Anti-Histone H2A.Z acetyl-Lys4/7/11, NeuroMab clone N299/39 |
| Anti-Histone H3.3, NeuroMab clone N158/28 |
| Anti-Histone H3 acetyl-Lys56, NeuroMab clone N307/12 |
| Anti-Histone H3-dimethyl-Arg8, NeuroMab clone N293/50 |
| Anti-Histone H3 pThr11, NeuroMab clone N123/19 |
| Anti-Histone H3 pThr11, NeuroMab clone N123/48 |
| Anti-Histone H4-dimethyl-Arg3, NeuroMab clone N309A/21 |
| Anti-Homer1L, NeuroMab clone L113/27 |
| Anti-Homer1L, NeuroMab clone L113/13 |
| Anti-Homer1, NeuroMab clone L113/130 |
| Anti-ICK, NeuroMab clone N451/73 |
| Anti-Iduna/RNF146, NeuroMab clone N201/35 |
| Anti-INPP4b, NeuroMab clone N171/17 |
| Anti IP3 receptor type 1 NeuroMab clone L24/18 |
| Anti-IRSp53/BAIAP2, NeuroMab clone L117/1 |
| Anti-JIP-2/IB-2, NeuroMab clone N135/37 |
| Anti-JMJD2A, NeuroMab clone N154/32 |
| Anti-KCC2 transporter, NeuroMab clone N1/66 |
| Anti-KCC2 transporter, NeuroMab clone N1/12 |
| Anti-KChIP1 potassium channel, NeuroMab clone K55/7 |
| Anti-KChIP2 potassium channel subunit, NeuroMab clone K60/73 |
| Anti-KChIP3 potassium channel, NeuroMab clone K66/38 |
| Anti-KChIP4 K+ channel, NeuroMab clone N423/75 |
| Anti-KCNT1/Slo2.2/Slack K+ channel, NeuroMab clone N3/26 |
| Anti-KCNT2/Slo2.1/Slick sodium- and chloride-activated ATP sensitive potassium channel, NeuroMab clone N11/33 |
| Anti-KCNU1/Slo3 pH-sensitive maxi potassium channel, NeuroMab clone N2/16 |
| Anti-Keyhole limpet hemocyanin, NeuroMab clone N132A/12 |
| Anti-Kir2.1 potassium channel, NeuroMab clone N112B/14 |
| Anti-Kir2.2 potassium channel, NeuroMab clone N124B/38 |
| Anti-Kir2.3 potassium channel, NeuroMab clone N25/35 |
| Anti-Kir2.4 potassium channel, NeuroMab clone N465/11 |
| Anti-Kir3.3 potassium channel, NeuroMab clone N455/15 |
| Anti-Kir6.1 potassium channel, NeuroMab clone N366/60 |
| Anti-Kir6.2 potassium channel, NeuroMab clone N363/71 |
| Anti-Kirrel3 short and long, NeuroMab clone N321C/49 |
| Anti-Kirrel3 short isoform 3, NeuroMab clone N320/48 |
| Anti-Kv1.1 potassium channel subunit, NeuroMab clone K20/78 |
| Anti-Kv1.1 potassium channel (external), NeuroMab clone K36/15 |
| Anti-Kv1.2 potassium channel subunit, NeuroMab clone K14/16 |
| Anti-Kv1.2 potassium channel subunit, NeuroMab clone L76/36 |
| Anti-Kv1.3 potassium channel, NeuroMab clone L23/27 |
| Anti-Kv1.4 potassium channel subunit, NeuroMab clone K13/31 |
| Anti-Kv1.4 potassium channel (extracellular), NeuroMab clone L71/5 |
| Anti-Kv1.5 potassium channel, NeuroMab clone K7/45 |
| Anti-Kv1.6 potassium channel subunit, NeuroMab clone K19/36 |
| Anti-Kv1.7 potassium channel, NeuroMab clone N471/27 |
| Anti-Kv11.3 potassium channel, NeuroMab clone N447/24 |
| Anti-Kv2.1 potassium channel subunit, NeuroMab clone L83/11 |
| Anti-Kv2.1 potassium channel subunit, NeuroMab clone K89/34 |
| Anti-Kv2.1 potassium channel subunit, NeuroMab clone L80/21 |
| Anti-Kv2.1 potassium channel (external), NeuroMab clone K39/25 |
| Anti-Kv2.2 potassium channel, NeuroMab clone K37/89 |
| Anti-Kv2.2 potassium channel, NeuroMab clone N372C/51 |
| Anti-Kv2.2 potassium channel, NeuroMab clone N372B/60 |
| Anti-Kv2.2 potassium channel, NeuroMab clone N372B/1 |
| Anti-Kv3.1b potassium channel, NeuroMab clone N16b/8 |
| Anti-Kv3.2 potassium channel, NeuroMab clone N410/17 |
| Anti-Kv3.3 potassium channel, NeuroMab clone N375/67 |
| Anti-Kv3.4 potassium channel, NeuroMab clone N72/16 |
| Anti-Kv4.2 potassium channel subunit, NeuroMab clone L28/4 |
| Anti-Kv4.2 potassium channel (external), NeuroMab clone K57/1 |
| Anti-Kv4.3 potassium channel subunit, NeuroMab clone K75/41 |
| Anti-Kv4.3 potassium channel subunit, NeuroMab clone K75/30 |
| Anti-Kv6.1 potassium channel, NeuroMab clone N474/27 |
| Anti-Kv6.4 potassium channel, NeuroMab clone N458/10 |
| Anti-KCNQ1 potassium channel, NeuroMab clone N37A/10 |
| Anti-KCNQ2 potassium channel, NeuroMab clone N26A/23 |
| Anti-KCNQ4 potassium channel, NeuroMab clone N43/6 |
| Anti-Kv8.2 potassium channel, NeuroMab clone N448/88 |
| Anti-Kv8.2 potassium channel, NeuroMab clone N448/50 |
| Anti-Kv9.1 potassium channel, NeuroMab clone N461/19 |
| Anti-Kv9.2 potassium channel, NeuroMab clone N460/19 |
| Anti-Kvβ1.1 potassium channel subunit, NeuroMab clone K9/40 |
| Anti-Kv1.2 potassium channel subunit, NeuroMab clone K47/42 |
| Anti-Kv尾2 potassium channel, NeuroMab clone K17/70 |
| Anti-Laforin, NeuroMab clone N84/37 |
| Anti-LAR/PTPRF, NeuroMab clone N165/38 |
| Anti-Lgi1, NeuroMab clone N283/7 |
| Anti-Lhx6.1, NeuroMab clone N228A/16 |
| Anti-LRP4 (cytoplasmic), NeuroMab clone N164/6 |
| Anti-LRP4 (extracellular), NeuroMab clone N207/27 |
| Anti-LRRK1, NeuroMab clone N341/37 |
| Anti-LRRK1, NeuroMab clone N341/12 |
| Anti-LRRK2/Dardarin, NeuroMab clone N241A/34 |
| Anti-LRRK2/Dardarin, NeuroMab clone N231B/34 |
| Anti-LRRK2/Dardarin, NeuroMab clone 8G10 |
| Anti-LRRK2/Dardarin, NeuroMab clone N138/6 |
| Anti-LRRK2/Dardarin-pSer910, NeuroMab clone 1D8 |
| Anti-LRRTM2, NeuroMab clone N209C/35 |
| Anti-LRRTM4, NeuroMab clone N205B/22 |
| Anti-Mad3, NeuroMab clone N129A/6 |
| Anti-Mad3, NeuroMab clone N129/15 |
| Anti-Malin, NeuroMab clone N85/18 |
| Anti-MBP (Maltose-binding protein), NeuroMab clone N128A/4 |
| Anti-MAP3K12, NeuroMab clone N377/20 |
| Anti-MAP3K12, NeuroMab clone N377/83 |
| Anti-MECP2, NeuroMab clone N227/21 |
| Anti-MESD, NeuroMab clone N88/12 |
| Anti-MFF, NeuroMab clone N382/14 |
| Anti-MFF (exon 1), NeuroMab clone N382/69 |
| Anti-MGL, NeuroMab clone N90/20 |
| Anti-mGluR1/5 (group I) glutamate receptor, NeuroMab clone N75/3 |
| Anti- mGluR1/5 (group I) glutamate receptor, NeuroMab clone N75/33 |
| Anti-Miro2, NeuroMab clone N384/63 |
| Anti-MiRP4 potassium channel, NeuroMab clone N472/88 |
| Anti-Mitofusin-1 (Mfn1), NeuroMab clone N111/24 |
| Anti-Mitofusin-2 (Mfn2), NeuroMab clone N153/5 |
| Anti-MMACHC, NeuroMab clone N230/21 |
| Anti-MMP9 metalloproteinase, NeuroMab clone L51/82 |
| Anti-MOG, NeuroMab clone L94/54 |
| Anti-Mortalin/GRP75, NeuroMab clone N52A/42 |
| Anti-MPP8, NeuroMab clone N119/44 |
| Anti-NALCN, NeuroMab clone N185/7 |
| Anti-Nav1.1 sodium channel, NeuroMab clone K74/71 |
| Anti-Nav1.2 sodium channel, NeuroMab clone K69/3 |
| Anti-Nav1.4 sodium channel, NeuroMab clone N255/38 |
| Anti-Nav1.5 sodium channel, NeuroMab clone N397/19 |
| Anti-Nav1.6 sodium channel, NeuroMab clone K87A/10 |
| Anti-Nav1.7 sodium channel, NeuroMab clone N68/6 |
| Anti-Nav1.8 sodium channel, NeuroMab clone N134/12 |
| Anti-Navbeta1 Na+ channel, NeuroMab clone N405/74 |
| Anti-Navbeta2 Na+ channel, NeuroMab clone N395/68 |
| Anti-Navbeta3 Na+ channel, NeuroMab clone N396/29 |
| Anti-Navbeta4 sodium channel, NeuroMab clone N168/6 |
| Anti-NCKX4, NeuroMab clone N414/25 |
| Anti-Neuregulin-CRD (Cysteine-rich domain, Type III), NeuroMab clone N126B/31 |
| Anti-Neuregulin-HBD (Heparin-binding domain, Type I/II), NeuroMab clone N120A/9 |
| Anti-Neurexin-1-Beta, NeuroMab clone N170A/1 |
| Anti-Neurexin-1-Beta, NeuroMab clone N170A/26 |
| Anti-Neuroligin-1, NeuroMab clone N97A/31 |
| Anti-Neuroligin-2, NeuroMab clone L107/39 |
| Anti-Neuroligin-3, NeuroMab clone N110/29 |
| Anti-Neuroligin-4*, NeuroMab clone N98/47 |
| Anti-Neuroligin-4*, NeuroMab clone N98/7 |
| Anti-NGL-1 (Netrin-G1 ligand), NeuroMab clone N49A/21 |
| Anti-NGL-2 (Netrin-G2 ligand) NeuroMab clone N50/36 |
| Anti-NGL-3 (Netrin-G3 ligand), NeuroMab clone N51/6 |
| Anti-NKCC1, NeuroMab clone N161/20 |
| Anti-NOS1/nNOS, NeuroMab clone L121/25 |
| Anti-NOS1/nNOS, NeuroMab clone L121/42 |
| Anti-Notch1, NeuroMab clone N253/32 |
| Anti-Npas4, NeuroMab clone N408/62 |
| Anti-Npas4, NeuroMab clone N408/79 |
| Anti-Neuropeptide Y, NeuroMab clone L115/13 |
| Anti-NPY2R, NeuroMab clone L119/106 |
| Anti-NrCAM, NeuroMab clone N343/26 |
| Anti-NSD1, NeuroMab clone N312/10 |
| Anti-NSD3, NeuroMab clone N348/82 |
| Anti-OCRL/INPP5b, NeuroMab clone N166A/26 |
| Anti-Olig1, NeuroMab clone N149/25 |
| Anti-Pan-Ankyrin, NeuroMab clone N388A/60 |
| Anti-Pancortin, NeuroMab clone K96/7 |
| Anti-Pan-FHF-A, NeuroMab clone N235/22 |
| Anti-Pan-Gamma-protocadherin-A, NeuroMab clone N144/32 |
| Anti-Pan-Gamma-protocadherin, NeuroMab clone N159/5 |
| Anti-Pan-GRK, NeuroMab clone N145/20 |
| Anti-Pan-KChIP potassium channel, NeuroMab clone K55/82 |
| Anti-Pan-Kv potassium channel, NeuroMab clone K40/17 |
| Anti-Pan-Kvbeta potassium channel, NeuroMab clone K25/73 |
| Anti-Pan-MAGUK scaffold proteins, NeuroMab clone K28/86 |
| Anti-Pan-Nav1 sodium channel, NeuroMab clone N419/40 |
| Anti-Pan-Nav1 sodium channel, NeuroMab clone N419/78 |
| Anti-pan-Neurofascin, NeuroMab clone L11A/41 |
| Anti-Pan-Neurofascin (external), NeuroMab clone A12/18 |
| Anti-Pannexin-2, NeuroMab clone N121A/1 |
| Anti-Pannexin-2, NeuroMab clone N121A/31 |
| Anti-Pan-PTPR, NeuroMab clone N165/43 |
| Anti-Pan-QKI, NeuroMab clone N147/6 |
| Anti-Pan-SAPAP, NeuroMab clone N127/31 |
| Anti-pan-Shank (SH3 and multiple ankyrin repeat domains protein) scaffold protein, NeuroMab clone N23B/49 |
| Anti-Pan-Synapsin, NeuroMab clone L125/129 |
| Anti-Pan-Thyroid hormone receptor, NeuroMab clone N403/63 |
| Anti-PARIS/ZNF746, NeuroMab clone N196/16 |
| Anti-Parvalbumin, NeuroMab clone L114/3 |
| Anti-Parvalbumin, NeuroMab clone L114/81 |
| Anti-PEX6, NeuroMab clone N233/8 |
| Anti-PEX7, NeuroMab clone N232/9 |
| Anti-Phosphoserine-2-OEt, NeuroMab clone N257/25 |
| Anti-Phosphoserine-2-OH, NeuroMab clone N259/48 |
| Anti-Phosphoserine-2-OMe, NeuroMab clone N262/16 |
| Anti-PhyH/PAHX, NeuroMab clone N210/5 |
| Anti-PICK1 scaffold, NeuroMab clone L20/8 |
| Anti-PINK1, NeuroMab clone N4/15 |
| Anti-PINK1, NeuroMab clone N4/49 |
| Anti-PINK1, NeuroMab clone N4/19 |
| Anti-PINK1, NeuroMab clone N357/6 |
| Anti-Proser1, NeuroMab clone N456/39 |
| Anti-Prrt2, NeuroMab clone N485/22 |
| Anti-PSD-93/Chapsyn-110 scaffold protein, NeuroMab clone N18/30 |
| Anti-PSD-93/Chapsyn-110 scaffold protein, NeuroMab clone N18/28 |
| Anti-PSD-95 MAGUK scaffold protein, NeuroMab clone K28/43 |
| Anti-PSD-95 MAGUK scaffold protein, NeuroMab clone K28/74 |
| Anti-QKI-5-NLS, NeuroMab clone N195A/16 |
| Anti-QKI-6, NeuroMab clone N182/17 |
| Anti-QKI-7, NeuroMab clone N183/15 |
| Anti-QKI-7b, NeuroMab clone N194/11 |
| Anti-RBM17/SPF45, NeuroMab clone N219/5 |
| Anti-REEP, NeuroMab clone N326D/13 |
| Anti-REEP1, NeuroMab clone N345/51 |
| Anti-REEP1/2, NeuroMab clone N326D/29 |
| Anti-REEP2, NeuroMab clone N326D/2 |
| Anti-Rem2, NeuroMab clone N324/2 |
| Anti-RGS14, NeuroMab clone N133/21 |
| Anti-RGS14, NeuroMab clone N133/35 |
| Anti-Rufy3, NeuroMab clone N483/84 |
| Anti-Rufy3, NeuroMab clone N483/126 |
| Anti-Rufy3, NeuroMab clone N483/26 |
| Anti-S100A5, NeuroMab clone N176A/35 |
| Anti-SALM2 synaptic adhesion-like molecule, NeuroMab clone N52B/27 |
| Anti-SALM5/LRFN5, NeuroMab clone N140A/12 |
| Anti-SAP102 MAGUK scaffold protein, NeuroMab clone N19/2 |
| Anti-SAP97 scaffold protein, NeuroMab clone K64/15 |
| Anti-SAPAP1, NeuroMab clone N238/29 |
| Anti-SAPAP1, NeuroMab clone N238/30 |
| Anti-SAPAP1/2, NeuroMab clone N238/31 |
| Anti-SAPAP2, NeuroMab clone N459/84 |
| Anti-SAPAP3, NeuroMab clone L126/93 |
| Anti-SCG10/stathmin-2, NeuroMab clone L5/1 |
| Anti-SH3GL1, NeuroMab clone K51/1 |
| Anti-Shank1/ SPANK-1/Synamon/SSTRIP scaffold protein, NeuroMab clone N22/21 |
| Anti-Shank1 and Shank3, NeuroMab clone N367/51 |
| Anti-Shank2/ProSAP1/Spank-3/CortBP1 scaffold protein,NeuroMab clone N23B/6 |
| Anti-Shank3 scaffold protein, NeuroMab clone N69/46 |
| Anti-Shank3, NeuroMab clone N367/62 |
| Anti-SK2 potassium channel, NeuroMab clone K78/29 |
| Anti-Slo1/BKAlpha potassium channel, NeuroMab clone L6/23 |
| Anti-Slo1/BKAlpha potassium channel, NeuroMab clone L6/48 |
| Anti-Slo1/BKAlpha potassium channel, NeuroMab clone L6/60 |
| Anti-Snapin (SNAP25 binding protein), NeuroMab clone L8/15 |
| Anti-SNAT1 Neurotransmitter Transporter NeuroMab clone N104/37 |
| Anti-SNAT1 Neurotransmitter Transporter NeuroMab clone N104/32 |
| Anti-SST/Somatostatin, NeuroMab clone L111/118 |
| Anti-S-tag, NeuroMab clone N56/9 |
| Anti-Stonin-2, NeuroMab clone N346/9 |
| Anti-SUR1, NeuroMab clone N289/16 |
| Anti-SUR1 and SUR2B, NeuroMab clone N323A/31 |
| Anti-SUR2A, NeuroMab clone N319A/14 |
| Anti-SUR2B, NeuroMab clone N323B/20 |
| Anti-SVOP, NeuroMab clone N356/9 |
| Anti-SVOP, NeuroMab clone N356/23 |
| Anti-Synapsin-III, NeuroMab clone L125/121 |
| Anti-Synaptotagmin-10, NeuroMab clone N269/73 |
| Anti-Synaptotagmin-12, NeuroMab clone N277/7 |
| Anti-Synaptotagmin-3, NeuroMab clone N278/19 |
| Anti-Synaptotagmin-5, NeuroMab clone N274/8 |
| Anti-Synaptotagmin-6, NeuroMab clone N270/47 |
| Anti-Synaptotagmin-7, NeuroMab clone N275/14 |
| Anti-Synaptotagmin-9, NeuroMab clone N276A/15 |
| Anti-SynCAM1 cell adhesion molecule, NeuroMab clone L45/30 |
| Anti-SynCAM4, NeuroMab clone N244/5 |
| Anti-SynDIG1/Tmem90b, NeuroMab clone L42/17 |
| Anti-SynDIG3/Tmem91, NeuroMab clone N160/21 |
| Anti-SynDIG4, NeuroMab clone L102/45 |
| Anti-Tafazzin, NeuroMab clone N173B/13 |
| Anti-TALK1 potassium channel, NeuroMab clone N466/14 |
| Anti-TARPGamma2/Stargazin, NeuroMab clone N245/1 |
| Anti-TARPGamma2/4/8, NeuroMab clone N245/36 |
| Anti-TASK1 potassium channel, NeuroMab clone N374/48 |
| Anti-Tauro-GM2, NeuroMab clone N175/9 |
| Anti-THAP1, NeuroMab clone N325B/65 |
| Anti-THIK-2 potassium channel, NeuroMab clone N468/37 |
| Anti-Thioredoxin, NeuroMab clone N245/44 |
| Anti-Thorase (Atad1), NeuroMab clone N125/10 |
| Anti-Thyroid hormone receptor beta1, NeuroMab clone N402/13 |
| Anti-Thyroid hormone receptor beta1, NeuroMab clone N402/46 |
| Anti- TRAAK potassium channel, NeuroMab clone N445/27 |
| Anti-TRAK1, NeuroMab clone N389/9 |
| Anti-TRAK2, NeuroMab clone N390/43 |
| Anti-TRESK potassium channel, NeuroMab clone N467/1 |
| Anti-TRIP8b (constant), NeuroMab clone N212/7 |
| Anti-TRIP8b (constant), NeuroMab clone N212/17 |
| Anti-TRIP8b (exon 1a/5 junction), NeuroMab clone N291C/22 |
| Anti-TRIP8b (exon 1b), NeuroMab clone N212A/34 |
| Anti-TRIP8b (exon 4), NeuroMab clone N212/3 |
| Anti-TrpC1 calcium channel, NeuroMab clone 1F1 |
| Anti-TrpC4 calcium channel, NeuroMab clone N77/15 |
| Anti-TrpC5 calcium channel, NeuroMab clone N67/15 |
| Anti-TrpC7 calcium channel, NeuroMab clone N64A/36 |
| Anti-TrpM4, NeuroMab clone L88/86 |
| Anti-TrpM6, NeuroMab clone N470/22 |
| Anti-TrpM7 ion channel and Ser/Thr kinase, NeuroMab clone N74/25 |
| Anti-TRPML3/Mucolipin-3, NeuroMab clone N268/19 |
| Anti-TrpV1, NeuroMab clone N221/17 |
| Anti-TrpV1, NeuroMab clone N221/12 |
| Anti-TrpV3 cation channel, NeuroMab clone N15/4 |
| Anti-TrpV3 cation channel, NeuroMab clone N15/39 |
| Anti-TWIK-2 potassium channel, NeuroMab clone N469/28 |
| Anti-Uncx, NeuroMab clone N155/9 |
| Anti-VAChT vesicular acetylcholine transporter, NeuroMab clone N6/38 |
| Anti-VAChT, NeuroMab clone N425/45 |
| Anti-VAPA, NeuroMab clone N479/12 |
| Anti-VAPA, NeuroMab clone N479/22 |
| Anti-VAPA/B, NeuroMab clone N479/107 |
| Anti-VDAC1, NeuroMab clone N152B/23 |
| Anti-Versican, NeuroMab clone N351/23 |
| Anti-Versican, NeuroMab clone N351/24 |
| Anti-VGAT, NeuroMab clone L118/80 |
| Anti-VGAT, NeuroMab clone L118/66 |
| Anti-VGlut1, NeuroMab clone N28/9 |
| Anti-VGlut2, NeuroMab clone N29/29 |
| Anti-VGlut3, NeuroMab clone N34/34 |
| Anti-VIP, NeuroMab clone L108/92 |
| Anti-VMAT1, NeuroMab clone N440/21 |
| Anti-VMAT1, NeuroMab clone N440/61 |
| Anti-Slc18a2/VMAT2, NeuroMab clone N449/73 |
| Anti-Zebrafish VSP/TPTE, NeuroMab clone N432/21 |
| Anti-Zebrafish VSP/TPTE, NeuroMab clone N432/63 |
| Anti-WAVE1/SCAR, NeuroMab clone K91/36 |
| Anti-WNK1, NeuroMab clone N391/68 |
| Anti-WRN, NeuroMab clone N428/12 |
| Zebrafish PSD Marker, NeuroMab clone N286/74 |
| Anti-Zinedin/Striatin-4, NeuroMab clone K88/64 |
| Anti-ZIP3, NeuroMab clone N476/9 |
| Anti-ZNF423, NeuroMab clone N328B/37 |

艾美捷科技代理Cytoskeleton品牌产品
Cytoskeleton, Inc.成立于1993年,主要专注于生产药物筛选、信号转导和细胞骨架研究相关产品。Cytoskeleton专门生产纯化蛋白质和易于使用的试剂盒,用于研究生物化学和细胞过程。
其中的试剂盒可用于基础研究或小规模筛选的少量样品(Biochem™试剂盒),也可用于大规模高通量筛选(CytoDYNAMIX screens™)。此外,Cytoskeleton还为微管、微管蛋白、运
动蛋白、小G蛋白效应子、GAP、GEF和其他几种蛋白质提供药物筛选服务。
< " data-original="http://prospec.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Cytoskeleton品牌产品"> 艾美捷科技代理Cytoskeleton品牌产品
Optocell公司是制药和生物技术市场上游生物工艺监控系统的可靠供应商。凭借对哺乳动物细胞、细菌、酵母和藻类培养的深入了解,Optocell支持在研发、工艺开发和生产阶段对生物工艺进行在线分析。
Optocell is a trusted supplier of monitoring systems for upstream bioprocesses to the Pharma and Biotech market. With the in-depth knowledge of the cultivation of mammalian cells, bacteria, yeast and algae we support the at-line analysis of bioprocesses in the stages of R&D, process development and production.
Optocell的主要产品包括:
BioMajesty
CuBiAn HT270
CuBiAn C125
Reagents
ConSta
LinSta
FocSta
ViaSta
LinSta EASY
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com

STRECK, Inc.成立于1971年,是一家行业领先的专注于临床和科研产品研发与生产的公司。STRECK秉承创新、品质、服务的理念,为患者提供更快速准确的检测结果。STRECK的核心为稳定保存系列产品,其包括Cell Free DNA BCT、Cell Free RNA BCT、Cyto-Chex BCT、Cell Free DNA Urine Preserve及STRECK Cell Preservative, 该系列产品已广泛应用于临床研究、药物研发及疾病诊断等领域。
Established in 1971, Streck’s founder, Dr. Wayne Ryan, developed the company’s core technology of cell stabilization at a time when blood cells were still being counted manually using microscopes. Dr. Ryan, with a fierce passion for science and innovation, discovered that by isolating and stabilizing platelets, our laboratory scientists were able to facilitate automatic counting, leading to the development of an accurate system for calibrating platelet-counting devices. It was a profound breakthrough for hematology laboratories around the world – one that fueled our pursuit of innovative solutions for the clinical laboratory.
<

Streck的主要产品包括:
(1)标物
Body Fluids
Flow Cytometry
Chemistry
Hematology
Sickle Cells
Urinalysis
(2)收集
Collect Tubes
Preservatives
Thermometers
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://prospec.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Streck"> Streck
艾美捷科技特约代理Bethyl Laboratories全系列产品。
Bethyl Laboratories公司是世界著名的一抗和二抗生产商,成立于1972年,美国农业部(USDA)认证企业,符合GMP标准。致力于给研究者提供高品质抗体。主要生产抗体为细胞生物学类。公司为临床和科研提供高品质的抗体生产和服务,拥有世界上最丰富的细胞凋亡产品。如:凯氏半胱氨酸蛋白酶分析试剂盒和试剂,细胞凋亡检测试剂盒及试剂,与细胞凋亡相关的抗体,细胞增殖和细胞毒性检测试剂盒,生长因子,细胞因子和趋化因子,分子生物学试剂盒及试剂等研究产品。此外,该公司生产的各种动物免疫球蛋白的elisa试剂盒,规格一般为10x96T,性价比优越,颇受广大科研工作者的亲睐。
Bethyl Laboratories, Inc. has been dedicated to supporting scientific discovery through its qualified antibody products and custom polyclonal antibody services since its founding in 1972. With over 45 years of experience, Bethyl is also a leading provider of custom polyclonal antibody production services. Bethyl offers complete packages from initial peptide synthesis to affinity purification of custom polyclonal antibodies from an antigen-specific immunosorbent. Most recently, our capabilities have expanded and we now offer contract recombinant rabbit monoclonal antibody partnerships.
Bethyl Laboratories公司的主要产品包括:
Cell Lysate Preparation
Western Blot (WB)
Immunoprecipitation
Immunohistochemistry (IHC)
ELISA
Proximity Ligation Assay (PLA)
Flow Cytometry
Dilutions
Terms and Abbreviations
" data-original="http://prospec.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技特约代理Bethyl Laboratories全系列产品"> 艾美捷科技特约代理Bethyl Laboratories全系列产品
RayBiotech is a leading life sciences company providing proteomic discovery tools. RayBiotech has nearly 150 employees whose objectives are to provide excellent products and service worldwide to RayBiotech customers which include scientists in industry, academic and research institutes in 41 countries. RayBiotech is committed to accelerating customer success through innovation and leadership in the Life Sciences.
RayBiotech公司致力于开发、研制、生产及销售以抗体芯片、ELISA/EIA、抗原抗体为主的酶免产品,不仅拥有强大的技术团队,其中40%博士及博士后学历,而且十分重视产品的科技创新,公司先后与哈佛大学、普林斯顿大学等国际多家权威科研机构、院校紧密合作,将技术进行广泛应用。世界各国众多科学家使用了RayBiotech的抗体芯片等酶免产品已发表数千篇文献在Nature、Nature Medicine、Cell、PNAS、Lancet 等世界顶级期刊上。客户对RayBiotech芯片技术和产品的质量都给予了肯定和很高的评价。以抗体芯片生产为核心,RayBiotech公司将生产线扩大到ELISA/EIA、抗原抗体等数万种产品,涵盖了免疫学领域大多数主要产品种类。经过10余年的发展和品牌积累,RayBiotech已成为国际上公认的蛋白芯片的先驱企业,抗体及酶免产品专家。
RayBiotech公司的主要产品包括:
(1)Arrays
Antibody Arrays
Glycobiology Arrays
Protein Arrays
Phosphorylation Arrays
(2)ELISA Kits
Sandwich ELISA Kits
EIA Kits
Transcription Factor Activity Assay Kits
Phosphorylation ELISA Kits
Post-Translational Modification ELISA Kits
Cell-Based Phosphorylation ELISA Kits
SpeedELISA Kits
IQELISA Kits
(3)Functional Assays
Cell Viability Assays
Lipid Transfer Assays
Luciferase Assays
Molecular Biology Assays
Oxidative Stress Assays
Phosphorylation Assays
Apoptosis Assays
Cytotoxicity Assays
Metabolism Assays
(4)Reagents
Antibodies
Proteins
Supplemental Reagents
(5)Flow Cytometry
Flow Cytometry Antibodies
Live/Dead Markers
Intracellular Staining Kits
(6)Other Products
Lab Equipment
Isotyping
Software
Cell Fractionation Kits
Protein Quantification
Magnetic Beads
Blood Collection
Kit Components
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://prospec.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="RayBiotech"> RayBiotech
艾美捷科技有限公司,代理GORYO Chemical公司全系列探针产品。
GORYO Chemical公司位于日本札幌市,是一家生产荧光探针的专业化供应商。由于荧光探针的化学特性,使得研究者可以利用它对细胞内运行机理进行可视化研究。GORYO Chemical与东京大学和北海道大学合作,在荧光试剂领域领已取得领先的地位。目前,GORYO Chemical在日本已经开始针对癌症检测推出临床使用的探针,在未来,这将为指导治疗提供新的方法。
<主要产品和服务:
| AcidiFluor™ Series | Fluorescent probes to detect acidic pH | Size |
| GC301 | AcidiFluor™ ORANGE | 10 μg × 20 |
| GC3011 | AcidiFluor™ ORANGE | 10 μg × 10 |
| GC302 | AcidiFluor™ ORANGE-NHS | 1 mg |
| GC303 | AcidiFluor™ ORANGE-NHS | 5 μg × 5 |
| GC304 | AcidiFluor™ ORANGE Labeling Kit | 5 times labeling |
| GC305 | AcidiFluor™ ORANGE-Zymosan A | 1 mg |
| GC306 | AcidiFluor™ ORANGE-Dextran 10k | 1 mg |
| GC309 | AcidiFluor™ ORANGE-Transferrin | 1 mg |
| GC310-01 | HaloTag® AcidiFluor™ ORANGE Ligand | 30 nmol |
| GC310-02 | HaloTag® AcidiFluor™ ORANGE Ligand | 60 nmol |
| CalxFluor™ Series | Fluorescent probes to detect calcium ions | Size |
| GC405 | CaSiR-1 potassium salt | 500 µg |
| GC503 | CaTM-2 AM | 500 μg |
| GC504 | CaTM-2 AM | 50 μg × 10 |
| GC5041 | CaTM-2 AM | 50 μg × 5 |
| GC507 | CaTM-3 AM | 40 nmol × 5 |
| GlycoFluor™ Series | Fluorescent probes to detect glycosidase activity | Size |
| GC601 | GlycoYELLOW™ –βGal | 50 μg × 10 |
| GC611 | GlycoGREEN™-βGal | 30 nmol × 5 |
| SK4001-01 | TokyoGreen®–βGal | 1 mg |
| SK4002-01 | TokyoGreen®–βGlu | 1 mg |
| SK4003-01 | TokyoGreen®–βGlcU(Na) | 1 mg |
| HaloFluor™ Series | Fluorescent probes combined with Halotag® ligand | Size |
| GC310-01 | HaloTag® AcidiFluor™ ORANGE Ligand | 30 nmol |
| GC310-02 | HaloTag® AcidiFluor™ ORANGE Ligand | 60 nmol |
| A201-01 | HaloTag® SaraFluor™ 650B ligand | 15 nmol |
| A201-02 | HaloTag ®SaraFluor™ 650B ligand | 15 nmol × 2 |
| ProteoFluor™ Series | Fluorescent probes to detect protease activity in cancer cell | Size |
| GC801 | ProteoGREEN™-gGlu | 20 μg × 10 |
| GC811 | EP-HMRG | 30 nmol x 5 |
| StemFluor™ Series | Fluorescent probes to detect human iPS/ES cells | Size |
| GC7001-01 | Kyoto Probe 1 (KP-1) | 10 μg × 5 |
| GC7001-02 | Kyoto Probe 1 (KP-1) | 10 μg × 10 |
| SaraFluor™ Series | Fluorescent probes for labeling/imaging | Size |
| ST1003-10 | SaraFluor™ 488-NHS | 5 nmol x 5 |
| ST1003-11 | SaraFluor™ 488-NHS | 1 mg |
| ST1003-15 | SaraFluor™ 488-NHS | 1 mg x 5 |
| ST1003-21 | SaraFluor™ 488-maleimide | 1 mg |
| ST1003-25 | SaraFluor™ 488-maleimide | 1 mg x 5 |
| ST1003-31 | SaraFluor™ 488-COOH | 1 mg |
| ST1003-35 | SaraFluor™ 488-COOH | 1 mg x 5 |
| ST1003-41 | SaraFluor™ 488-NH2 | 1 mg |
| ST1003-45 | SaraFluor™ 488-NH2 | 1 mg x 5 |
| ST1006-10 | SaraFluor™ 600-NHS | 5 nmol x 5 |
| ST1006-11 | SaraFluor™ 600-NHS | 1 mg |
| ST1006-15 | SaraFluor™ 600-NHS | 1 mg x 5 |
| ST1006-21 | SaraFluor™ 600-maleimide | 1 mg |
| ST1006-25 | SaraFluor™ 600-maleimide | 1 mg x 5 |
| ST1006-31 | SaraFluor™ 600-COOH | 1 mg |
| ST1006-35 | SaraFluor™ 600-COOH | 1 mg x 5 |
| ST1006-41 | SaraFluor™ 600-NH2 | 1 mg |
| ST1006-45 | SaraFluor™ 600-NH2 | 1 mg x 5 |
| ST1008-10 | SaraFluor™ 650-NHS | 5 nmol x 5 |
| ST1008-11 | SaraFluor™ 650-NHS | 1 mg |
| ST1008-15 | SaraFluor™ 650-NHS | 1 mg x 5 |
| ST1008-21 | SaraFluor™ 650-maleimide | 1 mg |
| ST1008-25 | SaraFluor™ 650-maleimide | 1 mg x 5 |
| ST1008-31 | SaraFluor™ 650-COOH | 1 mg |
| ST1008-35 | SaraFluor™ 650-COOH | 1 mg x 5 |
| ST1008-41 | SaraFluor™ 650-NH2 | 1 mg |
| ST1008-45 | SaraFluor™ 650-NH2 | 1 mg x 5 |
| ST1010-10 | SaraFluor™ 700-NHS | 5 nmol x 5 |
| ST1010-11 | SaraFluor™ 700-NHS | 1 mg |
| ST1010-15 | SaraFluor™ 700-NHS | 1 mg x 5 |
| ST1010-21 | SaraFluor™ 700-maleimide | 1 mg |
| ST1010-25 | SaraFluor™ 700-maleimide | 1 mg x 5 |
| ST1010-31 | SaraFluor™ 700-COOH | 1 mg |
| ST1010-35 | SaraFluor™ 700-COOH | 1 mg x 5 |
| ST1010-41 | SaraFluor™ 700-NH2 | 1 mg |
| ST1010-45 | SaraFluor™ 700-NH2 | 1 mg x 5 |
| ST1011-10 | SaraFluor™ 720-NHS | 5 nmol x 5 |
| ST1011-11 | SaraFluor™ 720-NHS | 1 mg |
| ST1011-15 | SaraFluor™ 720-NHS | 1 mg x 5 |
| ST1011-21 | SaraFluor™ 720-maleimide | 1 mg |
| ST1011-25 | SaraFluor™ 720-maleimide | 1 mg x 5 |
| ST1011-31 | SaraFluor™ 720-COOH | 1 mg |
| ST1011-35 | SaraFluor™ 720-COOH | 1 mg x 5 |
| ST1011-41 | SaraFluor™ 720-NH2 | 1 mg |
| ST1011-45 | SaraFluor™ 720-NH2 | 1 mg x 5 |
| A201-01 | HaloTag® SaraFluor™ 650B ligand | 15 nmol |
| A201-02 | HaloTag ®SaraFluor™ 650B ligand | 15 nmol × 2 |
| A202-01 | SaraFluor™ 650B goat anti-mouse IgG | 100 μg |
| A203-01 | SaraFluor™ 650B goat anti-rat IgG | 100 μg |
| A204-01 | SaraFluor™ 650B goat anti-rabbit IgG | 100 μg |
| A208-01 | SaraFluor™ 650B-NHS | 100 μg |
| A209-01 | SaraFluor™ 650B-maleimide | 100 μg |
| A218-01 | SaraFluor™ 488B-NHS | 100 μg |
| MetalloFluor™ Series | Fluorescent probes to detect metall ion | Size |
| GC901 | FeRhoNox™-1 | 50 μg × 10 |
| GC902 | CopperGREEN™ | 50 nmol × 5 |
| GC903-01 | FerroFarRed™ | 50 nmol × 5 |
| GC904-01 | FerroOrange | 35 nmol × 5 |
| GC904-02 | FerroOrange | 35 nmol × 1 |
| SK2001-01 | ZnAF®-2 | 1 mg |
| SK2002-01 | ZnAF®-2 DA | 1 mg |
| NOFluor™ Series | Fluorescent probes to detect niric oxide | Size |
| SK1001-01 | DAF-2 | 1 mg |
| SK1002-01 | DAF-2 DA | 1 mg |
| SK1003-01 | DAF-FM | 1 mg |
| SK1004-01 | DAF-FM DA | 1 mg |
| SK1005-01 | DAR-4M | 1 mg |
| SK1006-01 | DAR-4M AM | 1 mg |
| HypoFluor™ Series | Fluorescence probes for hypoxia detection | Size |
| A101-01 | MAR | 25 μg × 5 |
| ROSFluor™ Series | Fluorescent probes to detect reactive oxigen species | Size |
| SK3001-02 | Hydroxyphenyl Fluorescein (HPF) | 1 mg |
| SK3002-02 | Aminophenyl Fluorescein (APF) | 1 mg |
| SK3003-01 | NiSPY-3 | 1 mg |
| GC3004-01 | OxiORANGE™ | 100 nmol ×5 |
| GC3006-01 | HySOx | 20 μg × 5 |
| GC3007-01 | HYDROP | 30 nmol × 3 |
| GC3008-01 | HYDROP-EX | 30 nmol × 3 |
| FRETFluor™ Series | FRET based fluorescent probes | Size |
| A401-1 | QuicGSH3.0 | 25 nmol × 5 |
| A401-2 | QuicGSH3.0 | 25 nmol × 2 |
| A402-1 | SSip-1 DA | 60 nmol × 3 |
| NIRFluor™ series | Near infrared fluorescent probes | |
| A501-01 | ICG-NHS ester | 1 mg |
| A501-05 | ICG-NHS ester | 1 mg × 5 |
| A501-10 | ICG-NHS ester | 1 mg × 10 |
| A502-01 | ICG-maleimide | 1 mg |
| A502-05 | ICG-maleimide | 1 mg × 5 |
| A502-10 | ICG-maleimide | 1 mg × 10 |
| Bioluminescent series | Fluorescent probes for in vivo imaging | Size |
| RS101-01 | D-Luciferin potassium salt | 1 g |
| POLARIC™ Series | Fluorescent probes for staining cell membrane and bacteria | Size |
| GC101 | POLARIC™-500c6F | 1 μg × 10 |
| GC1011 | POLARIC™-500c6F | 1 μg × 5 |
| GC102 | POLARIC™-500BCS | 5 μg × 10 |
| GC1021 | POLARIC™-500BCS | 5 μg × 5 |
| GC2021 | POLARIC™-NHS | 1 mg |
| GC2031 | POLARIC™-maleimide | 1 mg |
| GC211 | POLARIC™ Labeling Kit | 5 times labelng |
更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://prospec.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="GORYO Chemical"> GORYO Chemical地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:15172431432
传真:18327026838
邮箱:sales@amyjet.com
0.3868